ArticleMaterials today. Bio2026
VEGF-sustained regulation and hydrogel-activated graded porous titanium scaffold for functional regeneration of the tendon-bone interface.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recapitulating the complex coupling mechanisms at the tendon-bone interface, which involve gradients in structure, composition, and mechanics, poses a primary challenge for healing. In this study, a 3D-printed graded porous Ti6Al4V scaffold was designed and fabricated to address this challenge. This scaffold features a gradient pore architecture tailored to the distinct requirements of both soft and hard tissues. The scaffold was further functionalized with a GelMA and silk fibroin hydrogel to activate the interface. Additionally, chitosan-stabilized BSA nanospheres loaded with VEGF were encapsulated within this hydrogel to achieve sustained release. In vitro studies demonstrated that this composite scaffold effectively promoted the migration and proliferation of tendon-derived stem cells, upregulated tenogenic marker genes, and enhanced angiogenic activity and synergistic osteogenesis. Animal model evaluations confirmed that the scaffold promoted the regeneration of type I collagen and Sharpey-like fibers, angiogenesis, and improved osseointegration, ultimately leading to a biologically continuous tendon-bone connection. The ultimate failure load of the repaired interface reached 107.61 ± 5.16 N, restoring 82% of the native enthesis strength. In conclusion, the synergistic strategy of "Structural Adaptation - Interface Activation - Signaling Regulation" presented in this study demonstrated the capacity to facilitate the regeneration of a biologically continuous tendon-bone interface in vivo and significantly improve functional integration. This approach provides a novel solution for enthesis regeneration and holds promise for clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.